<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JLCE</journal-id>
      <journal-title-group>
        <journal-title>Journal of Lung Cancer Epidemiology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">0000-0000</issn>
      <issn pub-type="ppub">0000-0000</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">JLCE-21-4024</article-id>
      <article-categories>
        <subj-group>
          <subject>review-article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Challenger Treatment of Various Cancers with T Cells Engineering</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Alireza</surname>
            <given-names>Heidari</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840592444">1</xref>
          <xref ref-type="aff" rid="idm1840686300">2</xref>
          <xref ref-type="aff" rid="idm1840685004">3</xref>
          <xref ref-type="aff" rid="idm1840687380">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Elena</surname>
            <given-names>Locci</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840592444">1</xref>
          <xref ref-type="aff" rid="idm1840686300">2</xref>
          <xref ref-type="aff" rid="idm1840685004">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silvia</surname>
            <given-names>Raymond</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840592444">1</xref>
          <xref ref-type="aff" rid="idm1840686300">2</xref>
          <xref ref-type="aff" rid="idm1840685004">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ricardo</surname>
            <given-names>Gobato</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840587940">5</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1840592444">
        <label>1</label>
        <addr-line>Faculty of Chemistry, California South University, 14731 Comet St, Irvine, CA 92604, USA.</addr-line>
      </aff>
      <aff id="idm1840686300">
        <label>2</label>
        <addr-line>BioSpectroscopy Core Research Laboratory, California South University, 14731 Comet St, Irvine, CA 92604, USA.</addr-line>
      </aff>
      <aff id="idm1840685004">
        <label>3</label>
        <addr-line>Cancer Research Institute, California South University, 14731 Comet St, Irvine, CA 92604, USA.</addr-line>
      </aff>
      <aff id="idm1840687380">
        <label>4</label>
        <addr-line>American International Standards Institute, Irvine, CA 92604, USA.</addr-line>
      </aff>
      <aff id="idm1840587940">
        <label>5</label>
        <addr-line>Green Land Landscaping and Gardening, Seedling Growth Laboratory, 86130-000, Paraná, Brazil.</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Ian</surname>
            <given-names>James Martins</given-names>
          </name>
          <xref ref-type="aff" rid="idm1840442524">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1840442524">
        <label>1</label>
        <addr-line>Edith Cowan University</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">Correspondence: Ricardo Gobato, Seedling Growth Laboratory, Green Land Landscaping and Gardening, Paraná 86130-000, Brazil; Email: <email>ricardogobato@hotmail.com</email>.</corresp>
        <fn fn-type="conflict" id="idm1841484956">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2023-04-13">
        <day>13</day>
        <month>04</month>
        <year>2023</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <fpage>43</fpage>
      <lpage>75</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>11</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>04</month>
          <year>2022</year>
        </date>
        <date date-type="online">
          <day>13</day>
          <month>04</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>Alireza Heidari, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/jlce/article/1950">This article is available from http://openaccesspub.org/jlce/article/1950</self-uri>
      <abstract>
        <p>Through T-cell engineering, researchers at the California South University (CSU) Cancer            Research Institute (CRI) have shown that tumor growth can be stopped in a variety of cancers and prevented from spreading to other tissues.         Findings from this study are the result of decades of research by Professor Ph.D. A. Heidari and our team of CSU, who discovered a protein called AH that can            inhibit the growth and spread of cancer cells in several different ways. They become in the tissues of the body. The T cells were armed with MDA-7/AH to target            cancer more widely. The engineering of T cells to produce MDA-7/AH causes cancer cells to be                     destroyed regardless of the expression of the target molecules. The tumor site is often very hostile to immune cells. It was found in the research that  MDA-7/AH can help T cells proliferate and increase the number of cancer cells. The T cells were armed with MDA-7/ AH to target cancer more widely. The engineering of T cells to produce MDA-7/AH causes cancer cells to be destroyed regardless of the expression of the target molecules. The tumor site is often very hostile to immune cells. We discovered that MDA-7/AH can help T cells proliferate and increase the number of cancer cells.</p>
      </abstract>
      <kwd-group>
        <kwd>Cancer</kwd>
        <kwd>Cells</kwd>
        <kwd>Tissues</kwd>
        <kwd>Tumors</kwd>
        <kwd>Prevention</kwd>
        <kwd>Prognosis</kwd>
        <kwd>Diagnosis</kwd>
        <kwd>Imaging</kwd>
        <kwd>Screening</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <page-count count="33"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1840419156" sec-type="intro">
      <title>Introduction</title>
      <p>At the subcellular level, MDA-7/AH binds to cell surface receptors and instructs them to make and          release more copies of the MDA-7/AH protein. If the cell is normal, the protein is easily secreted and does not cause harm, but if the cell is cancerous, MDA-7/AH causes            damage and eventual cell death not only in the primary tumor but also in the surrounding metastases; This is the cause of death in 90% of patients. As a result of this process, the immune system produces memory T cells that can be destroyed if the tumor returns to normal. Tumor levels of AH also prevent the formation of blood vessels, tumors that are very hungry and need nutrients to continue growing uncontrollably. In mice with prostate cancer, melanoma, or other cancer metastases, MDA-7 / AH-expressing T cells slowed or stopped cancer progression better than unmodified T cells. The                       researchers also found that arming T cells with MDA-7/AH allowed them to survive better and proliferate in the             microenvironment of the tumor (the space around the cancerous mass). <xref ref-type="bibr" rid="ridm1840804556">1</xref><xref ref-type="bibr" rid="ridm1840806716">2</xref><xref ref-type="bibr" rid="ridm1840817956">3</xref><xref ref-type="bibr" rid="ridm1840907236">4</xref><xref ref-type="bibr" rid="ridm1840669428">5</xref><xref ref-type="bibr" rid="ridm1840673676">6</xref><xref ref-type="bibr" rid="ridm1840671156">7</xref><xref ref-type="bibr" rid="ridm1840654356">8</xref><xref ref-type="bibr" rid="ridm1840650828">9</xref><xref ref-type="bibr" rid="ridm1840647588">10</xref><xref ref-type="bibr" rid="ridm1840629764">11</xref><xref ref-type="bibr" rid="ridm1840627028">12</xref><xref ref-type="bibr" rid="ridm1840601348">13</xref><xref ref-type="bibr" rid="ridm1840599116">14</xref><xref ref-type="bibr" rid="ridm1840595444">15</xref><xref ref-type="bibr" rid="ridm1840592996">16</xref><xref ref-type="bibr" rid="ridm1840608260">17</xref><xref ref-type="bibr" rid="ridm1840604444">18</xref><xref ref-type="bibr" rid="ridm1840575132">19</xref><xref ref-type="bibr" rid="ridm1840572252">20</xref><xref ref-type="bibr" rid="ridm1840571172">21</xref><xref ref-type="bibr" rid="ridm1840568580">22</xref><xref ref-type="bibr" rid="ridm1840564692">23</xref><xref ref-type="bibr" rid="ridm1840560660">24</xref><xref ref-type="bibr" rid="ridm1840534132">25</xref><xref ref-type="bibr" rid="ridm1840531972">26</xref><xref ref-type="bibr" rid="ridm1840530460">27</xref><xref ref-type="bibr" rid="ridm1840527796">28</xref><xref ref-type="bibr" rid="ridm1840525564">29</xref><xref ref-type="bibr" rid="ridm1840540252">30</xref><xref ref-type="bibr" rid="ridm1840500708">31</xref><xref ref-type="bibr" rid="ridm1840498332">32</xref><xref ref-type="bibr" rid="ridm1840495956">33</xref><xref ref-type="bibr" rid="ridm1840493940">34</xref><xref ref-type="bibr" rid="ridm1840490556">35</xref><xref ref-type="bibr" rid="ridm1840504668">36</xref><xref ref-type="bibr" rid="ridm1840474084">37</xref><xref ref-type="bibr" rid="ridm1840469980">38</xref><xref ref-type="bibr" rid="ridm1840468324">39</xref><xref ref-type="bibr" rid="ridm1840462924">40</xref><xref ref-type="bibr" rid="ridm1840461844">41</xref><xref ref-type="bibr" rid="ridm1840459756">42</xref><xref ref-type="bibr" rid="ridm1840456804">43</xref><xref ref-type="bibr" rid="ridm1840454428">44</xref><xref ref-type="bibr" rid="ridm1840451044">45</xref><xref ref-type="bibr" rid="ridm1840480708">46</xref><xref ref-type="bibr" rid="ridm1840477828">47</xref><xref ref-type="bibr" rid="ridm1840476460">48</xref><xref ref-type="bibr" rid="ridm1840411124">49</xref><xref ref-type="bibr" rid="ridm1840408964">50</xref><xref ref-type="bibr" rid="ridm1840405868">51</xref><xref ref-type="bibr" rid="ridm1840403708">52</xref><xref ref-type="bibr" rid="ridm1840399964">53</xref><xref ref-type="bibr" rid="ridm1840395860">54</xref><xref ref-type="bibr" rid="ridm1840394708">55</xref><xref ref-type="bibr" rid="ridm1840391900">56</xref><xref ref-type="bibr" rid="ridm1840388300">57</xref><xref ref-type="bibr" rid="ridm1840386140">58</xref><xref ref-type="bibr" rid="ridm1840383764">59</xref><xref ref-type="bibr" rid="ridm1840381172">60</xref><xref ref-type="bibr" rid="ridm1840339916">61</xref><xref ref-type="bibr" rid="ridm1840337180">62</xref><xref ref-type="bibr" rid="ridm1840333940">63</xref><xref ref-type="bibr" rid="ridm1840332356">64</xref><xref ref-type="bibr" rid="ridm1840329980">65</xref><xref ref-type="bibr" rid="ridm1840326452">66</xref><xref ref-type="bibr" rid="ridm1840323644">67</xref><xref ref-type="bibr" rid="ridm1840320548">68</xref><xref ref-type="bibr" rid="ridm1840319972">69</xref><xref ref-type="bibr" rid="ridm1840314644">70</xref><xref ref-type="bibr" rid="ridm1840311620">71</xref><xref ref-type="bibr" rid="ridm1840266452">72</xref><xref ref-type="bibr" rid="ridm1840265876">73</xref><xref ref-type="bibr" rid="ridm1840261628">74</xref><xref ref-type="bibr" rid="ridm1840257596">75</xref><xref ref-type="bibr" rid="ridm1840256012">76</xref><xref ref-type="bibr" rid="ridm1840254356">77</xref><xref ref-type="bibr" rid="ridm1840247732">78</xref><xref ref-type="bibr" rid="ridm1840247012">79</xref><xref ref-type="bibr" rid="ridm1840244708">80</xref><xref ref-type="bibr" rid="ridm1840240964">81</xref><xref ref-type="bibr" rid="ridm1840272140">82</xref><xref ref-type="bibr" rid="ridm1840199004">83</xref><xref ref-type="bibr" rid="ridm1840196268">84</xref><xref ref-type="bibr" rid="ridm1840193100">85</xref><xref ref-type="bibr" rid="ridm1840192308">86</xref><xref ref-type="bibr" rid="ridm1840187484">87</xref><xref ref-type="bibr" rid="ridm1840185468">88</xref><xref ref-type="bibr" rid="ridm1840181364">89</xref><xref ref-type="bibr" rid="ridm1840180716">90</xref><xref ref-type="bibr" rid="ridm1840175316">91</xref><xref ref-type="bibr" rid="ridm1840172220">92</xref><xref ref-type="bibr" rid="ridm1840170132">93</xref><xref ref-type="bibr" rid="ridm1840168620">94</xref><xref ref-type="bibr" rid="ridm1840164516">95</xref><xref ref-type="bibr" rid="ridm1840162284">96</xref><xref ref-type="bibr" rid="ridm1840158756">97</xref><xref ref-type="bibr" rid="ridm1840155444">98</xref><xref ref-type="bibr" rid="ridm1840152348">99</xref><xref ref-type="bibr" rid="ridm1840150260">100</xref>.</p>
    </sec>
    <sec id="idm1840417068" sec-type="results">
      <title>Results and Discussion</title>
      <p>The site of the tumor is often very hostile to             immune cells. We discovered that MDA-7/AH can help T cells proliferate and increase the number of cancer cells. In the clinic, the procedure involves extracting the                   patient's own T cells from tumor samples, genetically             engineering them to express MDA-7/AH, growing millions of copies of the cells in the laboratory, and finally                      transplanting them back into the patient. Using federal production standards, this method is generally safer and less invasive. CAR-T cells can also be engineered to express MDA-7/AH. For greater effectiveness, MDA-7/AH cells may be used in conjunction with other therapies. Clinical trials using various AH transmission methods are currently underway for several cancers. A phase 1 trial using adeno (cold-like virus) to deliver MDA-7/IL24 to a tumor has shown about 44% efficacy against various forms of cancer.</p>
      <p>According to Liu Z. et al. (2021)  taken together, arming T cells with tumoricidal and                     immune-potentiating MDA-7/IL24 confers new capabilities of eradicating antigen-negative cancer cell clones and improving T-cell expansion within tumors. This promising approach may be used to optimize cellular immunotherapy for treating heterogeneous solid cancers and provide a mechanism for inhibiting tumor escape.</p>
      <p>The results of Liu Z. et al. (2021) appear to be promising, as well as the techniques employed by the research team led by Professor Ph.D. A. Heidari and our team of CSU, discovered two new ways to induce tumor cell death, activating ferroptosis, where: first, iron-dependent cell death due to oxidative stress, and second, oxidative stress. Therefore, cell death can also be induced in a different way. Both types of cell death must be caused by drugs at the same time to eliminate the majority of the tumor mass.</p>
    </sec>
    <sec id="idm1840418940" sec-type="conclusions">
      <title>Conclusions</title>
      <p>The T cells were armed with MDA-7/AH to target cancer more widely. The engineering of T cells to produce MDA-7/AH causes cancer cells to be destroyed regardless of the expression of the target molecules. The tumor site is often very hostile to immune cells. We discovered that MDA-7/AH can help T cells proliferate and increase the number of cancer cells.</p>
      <p>A techniques employed by the research team led by biologist Dr. Raymond discovered two new ways to induce tumor cell death, activating ferroptosis, where: first, iron-dependent cell death due to oxidative stress, and second, oxidative stress. Therefore, cell death can also be induced in a different way. Both types of cell death must be caused by drugs at the same time to eliminate the majority of the tumor mass.</p>
    </sec>
    <sec id="idm1840417932">
      <title>Acknowledgment</title>
      <p>This study was supported by the Cancer Research Institute (CRI) Project of Scientific Instrument and               Equipment Development, the National Natural Science Foundation of the United Sates, the International Joint Bio Spectroscopy Core Research Laboratory Program supported by the California South University (CSU), and the Key project supported by the American International Standards Institute (AISI), Irvine, California, USA. </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1840804556">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cells”</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>J Nanomed Res</source>
          <volume>2</volume>
          <fpage>20</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840806716">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles”</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>International Journal of Pharmacology, Phytochemistry and Ethnomedicine</source>
          <volume>1</volume>
          <fpage>15</fpage>
          <lpage>19</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840817956">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Int J Adv Technol</source>
          <volume>7</volume>
          <fpage>007</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840907236">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Pharmacogn Nat Prod</source>
          <volume>2</volume>
          <fpage>103</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840669428">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Complexes”, J Bioeng Biomed Sci S:</source>
          <volume>006</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840673676">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math</source>
          <volume>5</volume>
          <fpage>142</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840671156">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and1HNMR Spectroscopies”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Biomol Res Ther</source>
          <volume>5</volume>
          <fpage>146</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840654356">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Bioanal Biomed</source>
          <volume>8</volume>
          <fpage>135</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840650828">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells”, Adv Cancer Prev 1: e102</article-title>
          <date>
            <year>2016</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1840647588">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Biotechnol Biomater</source>
          <volume>6</volume>
          <fpage>125</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840629764">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA:</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>A Biospectroscopic and Photobiological Study”, J Res Development</source>
          <volume>4</volume>
          <fpage>144</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840627028">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding”, Biochem Physiol</source>
          <volume>5</volume>
          <fpage>146</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840601348">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>DNA of Cancer Cells: A Photodynamic Therapy Study”, Arch Cancer Res</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840599116">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Arch Cancer Res</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840595444">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd:</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>YAG Lasers”, Arch Cancer Res</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840592996">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach”, Ann Clin Lab Res</article-title>
          <date>
            <year>2016</year>
          </date>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840608260">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Biomedical Sci</source>
          <volume>5</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840604444">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Measurement the Amount of Vitamin</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Biom Biostat</source>
          <chapter-title>D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniques”</chapter-title>
          <volume>7</volume>
          <fpage>292</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840575132">
        <label>19.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Spectroscopy and Quantum Mechanics of the Helium Dimer</article-title>
          <date>
            <year>2016</year>
          </date>
          <chapter-title>(He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations”, Chem Sci J 7: e112</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1840572252">
        <label>20.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Drug Metab Toxicol</source>
          <volume>7</volume>
          <fpage>129</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840571172">
        <label>21.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti–Cancer Drug in Formation of</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Nucleic Acids Complexes for Human Cancer Cells’ Treatment”, Biochem Pharmacol (Los Angel)</source>
          <volume>5</volume>
          <fpage>207</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840568580">
        <label>22.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storage”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Struct Chem Crystallogr Commun</source>
          <volume>2</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840564692">
        <label>23.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells”, Pharm Anal Chem Open Access 2: 113</article-title>
          <date>
            <year>2016</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1840560660">
        <label>24.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment”, Chemo Open Access 5: e129</article-title>
          <date>
            <year>2016</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1840534132">
        <label>25.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Pharmacokinet Exp Ther</source>
          <volume>1</volume>
          <fpage>005</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840531972">
        <label>26.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Insights Anal Electrochem</source>
          <volume>2</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840530460">
        <label>27.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptors”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Heavy Met Toxicity Dis</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840527796">
        <label>28.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs”, Insights Med Phys</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840525564">
        <label>29.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Translational Biomedical Approach to Structural Arrangement of Amino Acids’</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Complexes: A Combined Theoretical and Computational Study”, Transl Biomed</source>
          <volume>7</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840540252">
        <label>30.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Ab Initio and Density Functional Theory (DFT)</article-title>
          <date>
            <year>2016</year>
          </date>
          <chapter-title>Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells”, J Nanomedine Biotherapeutic Discov 6: e144</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1840500708">
        <label>31.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity</article-title>
          <date>
            <year>2016</year>
          </date>
          <chapter-title>LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study”, J Glycobiol 5: e111</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1840498332">
        <label>32.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Synthesis and Study of 5–[(Phenylsulfonyl)Amino]–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques”, Transl Med (Sunnyvale) 6: e138</article-title>
          <date>
            <year>2016</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1840495956">
        <label>33.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Electronic J Biol</source>
          <volume>12</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840493940">
        <label>34.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Austin J Anal Pharm Chem</source>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>1058</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840490556">
        <label>35.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Phase, Composition and Morphology Study and Analysis of</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Os–Pd/HfC Nanocomposites”, Nano Res Appl</source>
          <volume>2</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840504668">
        <label>36.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>International Journal of Advanced Chemistry</source>
          <volume>4</volume>
          <issue>1</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840474084">
        <label>37.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Arch Can Res</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840469980">
        <label>38.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS)</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Drugs”, J Data Mining Genomics &amp; Proteomics</source>
          <volume>7</volume>
          <fpage>125</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840468324">
        <label>39.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>DNA/RNA Molecules of Human Cancer Cells”, J Pharmacogenomics Pharmacoproteomics</source>
          <volume>7</volume>
          <fpage>153</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840462924">
        <label>40.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approach”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Transl Biomed</source>
          <volume>7</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840461844">
        <label>41.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP)</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Method”, Arch Can Res</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840459756">
        <label>42.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Cheminformaticsand System Chemistryof Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs:</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>A Combined Computational and Experimental Study”, J Inform Data Min</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840456804">
        <label>43.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano Drugs”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Integr Oncol</source>
          <volume>5</volume>
          <fpage>110</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840454428">
        <label>44.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Nanosci Curr Res</source>
          <volume>1</volume>
          <fpage>101</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840451044">
        <label>45.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO) Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drug”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Int J Drug Dev &amp; Res</source>
          <volume>8</volume>
          <fpage>007</fpage>
          <lpage>008</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840480708">
        <label>46.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Pharmacovigil</source>
          <volume>4</volume>
          <fpage>161</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840477828">
        <label>47.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Nanotechnology in Preparation of Semipermeable Polymers”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Adv Chem Eng</source>
          <volume>6</volume>
          <fpage>157</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840476460">
        <label>48.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for Analysis</article-title>
          <date>
            <year>2016</year>
          </date>
          <chapter-title>5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiations”, J Gastrointest Dig Syst 6: e119</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1840411124">
        <label>49.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives”, Biomedical Data Mining 5: e102</article-title>
          <date>
            <year>2016</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1840408964">
        <label>50.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>“A</surname>
            <given-names/>
          </name>
          <article-title>Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Using Genetic Function Approximation (GFA) Algorithm”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Mol Biol Biotechnol</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840405868">
        <label>51.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160and C3840Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Material Sci Eng</source>
          <volume>5</volume>
          <fpage>282</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840403708">
        <label>52.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs)</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)”, J Appl Computat Math</source>
          <volume>5</volume>
          <fpage>143</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840399964">
        <label>53.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>The Impact of High Resolution Imaging on Diagnosis”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Int J Clin Med Imaging</source>
          <volume>3</volume>
          <fpage>1000</fpage>
          <lpage>101</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840395860">
        <label>54.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid) and Tretinoin (All–Trans Retinoic Acid (ATRA)) Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF) and Density Functional Theory (DFT)</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Methods”, Insights in Biomed</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840394708">
        <label>55.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Advances in Logic</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Operations and Computational Mathematics”, J Appl Computat Math</source>
          <volume>5</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840391900">
        <label>56.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Mathematical Equations in Predicting Physical Behavior”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Appl Computat Math</source>
          <volume>5</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840388300">
        <label>57.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Chemotherapy a Last Resort for Cancer Treatment”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Chemo Open Access</source>
          <volume>5</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840386140">
        <label>58.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation and Various Analytical Methods”, Mass Spectrom Purif Tech 2: e101</article-title>
          <date>
            <year>2016</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1840383764">
        <label>59.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithm”, Insight Pharm Res</article-title>
          <date>
            <year>2016</year>
          </date>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840381172">
        <label>60.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Properties Relationship (QSPR)</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Studies”, Int J Clin Med Imaging</source>
          <volume>3</volume>
          <fpage>516</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840339916">
        <label>61.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Novel Approach to Biology”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Electronic J Biol</source>
          <volume>12</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840337180">
        <label>62.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Innovative Biomedical Equipment’s for Diagnosis and Treatment”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Bioengineer &amp; Biomedical Sci</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840333940">
        <label>63.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends</article-title>
          <date>
            <year>2016</year>
          </date>
          <chapter-title>in Oncology Medicine and Practices”, J Oncol Med &amp; Pract</chapter-title>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840332356">
        <label>64.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectives”</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>J Bioengineer &amp; Biomedical Sci</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840329980">
        <label>65.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container Design”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Powder Metall Min</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840326452">
        <label>66.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Arch Chem Res</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840323644">
        <label>67.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis: Number of Mutations in a Synchronous Tumor Varies by Age and Type of Synchronous Cancer”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Appl Bioinforma Comput Biol</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840320548">
        <label>68.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs) as Qubits for Quantum Computing”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Glob J Res Rev</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840319972">
        <label>69.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation ofAu38–xAgx/xCux(SPh–tBu)24to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Nanomater Mol Nanotechnol</source>
          <volume>6</volume>
          <fpage>3</fpage>
          <publisher-loc>(SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60and</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1840314644">
        <label>70.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Biomedical Resource Oncology and Data Mining to Enable Resource Discovery in</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Medical, Medicinal, Clinical, Pharmaceutical,Chemical and Translational Research and Their Applications in Cancer Research”, Int J Biomed Data Min</source>
          <volume>6</volume>
          <fpage>103</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840311620">
        <label>71.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Olympiadane Nanomolecules asAgent for Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy under Synchrotorn Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Dev Drugs</source>
          <volume>6</volume>
          <fpage>154</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840266452">
        <label>72.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer&amp;apos;s, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Stroke”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Bioengineer &amp; Biomedical Sci</source>
          <volume>7</volume>
          <fpage>127</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840265876">
        <label>73.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Opinion on Computational Fluid Dynamics (CFD)</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Technique”, Fluid Mech Open Acc</source>
          <volume>4</volume>
          <fpage>157</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840261628">
        <label>74.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Clusters”, J Surgery Emerg Med</source>
          <volume>1</volume>
          <publisher-loc>Au329–xAgx(SR)84, Au144(SR)60,Au68(SR)36,Au30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24andAu25(pMBA)18 Nano</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1840257596">
        <label>75.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Developmental Cell BiologyinAdult Stem CellsDeath and Autophagyto Trigger a PreventiveAllergic Reactionto Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy)”, Cell Biol (Henderson</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>NV</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840256012">
        <label>76.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Powder Metall Min</source>
          <chapter-title>in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma</chapter-title>
          <volume>6</volume>
          <fpage>170</fpage>
          <publisher-loc>Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1840254356">
        <label>77.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti–Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Am J Drug Deliv</source>
          <volume>5</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840247732">
        <label>78.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Clinical Trials of Dendritic Cell Therapies for CancerExposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech&amp;apos;s Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Biol Med Science</source>
          <volume>1</volume>
          <fpage>103</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840247012">
        <label>79.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Delivery”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Br Biomed Bull</source>
          <volume>5</volume>
          <fpage>305</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840244708">
        <label>80.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Integrative Approach to Biological Networks for Emerging Roles of Proteomics</article-title>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiation”, Transcriptomics 5: e117</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1840240964">
        <label>81.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Elimination of the Heavy Metals Toxicity and Diseases</article-title>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>in Disruption of Extracellular Matrix (ECM) Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiation”, Lett Health Biol Sci</chapter-title>
          <volume>2</volume>
          <issue>2</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840272140">
        <label>82.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs)</article-title>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Coated with Nano Graphene Oxide (GO) and Protonated Polyaniline (PANI) in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiation”, Br J Res</chapter-title>
          <volume>4</volume>
          <issue>3</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840199004">
        <label>83.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidity”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Res Rep Gastroenterol</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840196268">
        <label>84.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Synthesis,Pharmacokinetics,Pharmacodynamics,Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to Prevent Cardiovascular Diseaseunder Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Pharm Sci Emerg Drugs</source>
          <volume>5</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840193100">
        <label>85.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics throughParticle Therapy Acceleratorswith Monochromatic Microbeams”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Cell Biol Mol Sci</source>
          <volume>2</volume>
          <issue>1</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840192308">
        <label>86.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB) Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Nanotechnol Material Sci</source>
          <volume>4</volume>
          <issue>2</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840187484">
        <label>87.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Gobato</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSi”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Science Journal of Analytical Chemistry</source>
          <volume>5</volume>
          <fpage>76</fpage>
          <lpage>85</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840185468">
        <label>88.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Med Oncol</source>
          <volume>1</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840181364">
        <label>89.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Am J Ethnomed</source>
          <volume>4</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840180716">
        <label>90.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer&amp;apos;s Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Med Chem Toxicol</source>
          <volume>2</volume>
          <issue>3</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840175316">
        <label>91.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET)</article-title>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment”, Parana Journal of Science and Education (PJSE)–v.3, n.4</chapter-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1840172220">
        <label>92.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Open J Anal Bioanal Chem</source>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>014</fpage>
          <lpage>020</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840170132">
        <label>93.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Enz Eng</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840168620">
        <label>94.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)”, Mod Appro Drug Des</article-title>
          <date>
            <year>2017</year>
          </date>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>000504</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840164516">
        <label>95.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS)</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells”, J Proteomics Enzymol</source>
          <volume>6</volume>
        </mixed-citation>
      </ref>
      <ref id="ridm1840162284">
        <label>96.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Pharm Pharmaceutics</source>
          <volume>4</volume>
          <issue>2</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840158756">
        <label>97.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Ann Adv Chem</source>
          <volume>1</volume>
          <issue>2</issue>
          <fpage>061</fpage>
          <lpage>069</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840155444">
        <label>98.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>J Transl Res</source>
          <volume>1</volume>
          <issue>1</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1840152348">
        <label>99.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention</article-title>
          <date>
            <year>2017</year>
          </date>
          <chapter-title>Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica”, Current Trends Anal Bioanal Chem</chapter-title>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>36</fpage>
          <lpage>41</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1840150260">
        <label>100.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heidari</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiation”</article-title>
          <date>
            <year>2017</year>
          </date>
          <source>Arch Biotechnol Biomed</source>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>067</fpage>
          <lpage>0100</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
